Heart Test Laboratories, Inc.
NasdaqCM HSCS
Heart Test Laboratories, Inc. Inventory for the quarter ending October 31, 2024: USD 652.91 M
Heart Test Laboratories, Inc. Inventory is USD 652.91 M for the quarter ending October 31, 2024, a 96,650.04% change year over year. Inventory is the value of goods held by a company for sale or used in the production process.
-
Heart Test Laboratories, Inc. Inventory for the quarter ending October 31, 2023 was USD 674.84 K.
Key data
| Date | Inventory | Goodwill | Total Assets | Current Liabilities |
|---|
Market news
Loading...
NasdaqCM: HSCS
| CEO | Mr. Andrew Simpson |
| IPO Date | June 16, 2022 |
| Location | United States |
| Headquarters | 550 Reserve Street |
| Employees | 15 |
| Sector | Health Care |
| Industries | |
Description
Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional 12-lead resting ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.
Key trends
Past 5 years
Similar companies
Tenon Medical, Inc.
USD 1.67
-3.47%
Bioventus Inc.
USD 8.87
-3.17%
Bluejay Diagnostics, Inc.
USD 3.36
-7.95%
Nuwellis, Inc.
USD 1.05
3.96%
NeuroMetrix, Inc.
USD 3.98
-0.75%
ReShape Lifesciences Inc.
USD 4.66
-6.80%
StockViz Staff
January 16, 2025
Any question? Send us an email